Magnolia Innovation

What Magnolia Innovation does

Magnolia Innovation is a US-based, privately-held specialized healthcare and pharmaceutical market research consultancy headquartered in Bridgewater, New Jersey, and operating as a subsidiary brand within the Medical Knowledge Group (MKG) holding company. Founded around 2013 (per firmographic data; the firm's own source material does not explicitly confirm a founding year), Magnolia serves innovative pharmaceutical, biotech, medtech, and patient-advocacy clients through six core service pillars: Market Research, Healthcare Market Strategy, Market Access, HCP & Patient Analytics, Training, and Market Research Panels. The firm is differentiated by deep therapeutic-area expertise (oncology, rare disease, neurology, cardiology, and others) and by an anthropological, qualitative-led approach that is reinforced by the proprietary Scout Report insight-management platform, which links primary research, competitive intelligence, claims data, and secondary resources into a structured scorecard, and by the 2024 acquisition of Flince Research + Design for ethnographic methods. AI capabilities are layered on top of the research practice (NLP, sentiment analysis, generative AI exploration, knowledge retrieval) rather than sold as a standalone product.

The business model is a project-based professional services and managed services revenue model, with bespoke engagements scoped per project and quoted via a 'Partner With Us' contact form; pricing is not publicly disclosed. Go-to-market is partner-led, direct enterprise sales sourced through the firm website, industry referrals, thought-leadership content, and event presence (PMRC 2025, ASCO 2024, ISPOR Europe 2023). Named customer engagements include Biohaven (market research consultancy of record for migraine launch against AbbVie), Alnylam (PH1 natural history research), and BMT InfoNet (pro-bono patient community research), with a stated client mix spanning large pharma, early-stage biotech, medtech, and nonprofits. Magnolia is recognized on the MM+M Agency 100 List in 2024 and holds EU-U.S., UK Extension, and Swiss-U.S. Data Privacy Framework certifications, supporting international engagements.

Name

Magnolia Innovation

Legal name

Magnolia Innovation, LLC

Website

https://magnoliainnovation.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Magnolia Innovation is a US-based boutique healthcare and pharmaceutical market research consultancy serving pharma, biotech, medtech, and patient-advocacy clients with qualitative and quantitative research, market access, analytics, and training, augmented by the proprietary Scout Report insight platform.

Ownership category

akta.pro rank

Product category

Healthcare Market Research

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613), Marketing Research and Public Opinion Polling (54191)

SIC

Services-Management Consulting Services (8742), Services-Advertising Agencies (7311), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Innovation, Product & R&D Consulting (BPAHACAM)

akta.pro secondary industries

Strategy & Corporate Development Consulting (BPAHACAA), Product & Innovation Research (Concept, Pricing, Packaging, Conjoint) (MPAAALAI)

Keywords

• Pharmaceutical market research
• Healthcare market research
• Market access strategy
• Qualitative market research
• HCP and patient analytics

Headquarters

HQ city

Hoboken

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Market research and consulting services: Fee-based professional services delivered across the healthcare product lifecycle, including primary qualitative and quantitative market research, market access strategy, HCP and patient analytics, customized training, and custom research panels for pharmaceutical, biotech, medtech, and patient-advocacy clients. Engagements are project-based and quoted on a per-engagement basis through the 'Partner With Us' contact form.
2. Custom research panels and ongoing advisory engagements: Recurring/managed advisory and panel-based engagements that provide continuous market research and custom panels, complementing one-off project work.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Magnolia Innovation is a specialized healthcare and pharmaceutical market research consultancy that delivers primary qualitative and quantitative research, healthcare market strategy, market access services, HCP and patient analytics, customized training, and custom research panels to pharmaceutical, biotech, medtech, and patient-advocacy clients. Engagements span the full product lifecycle, from foundational pre-launch strategy through launch readiness and post-launch optimization, and are delivered by named senior partners. The firm complements these services with a proprietary insight-management solution (Scout Report) and an in-house claims database used for health-equity and clinical trial recruitment work.

Product overview

Magnolia Innovation is a single unified specialized market research consultancy for healthcare, pharmaceutical, and medtech clients, organized around six core service pillars: Market Research, Healthcare Market Strategy, Market Access, HCP & Patient Analytics, Training, and Market Research Panels. These six pillars work together across the full brand lifecycle — from foundational strategy through product launch readiness to post-launch support — and are complemented by the proprietary Scout Report insight-connection solution (which links primary research, competitive intelligence, and claims data into a structured scorecard) and by Flince Research, the qualitative and ethnographic research subsidiary that joined the Magnolia Innovation and Medical Knowledge Group family. Magnolia also positions itself within the larger Medical Knowledge Group (MKG) network, leveraging in-house medical affairs and data science teams.

Differentiator

Problem solved

Functional benefit

Brands

• Flince Research + Design: Specializes in qualitative and ethnographic research methodologies that bridge healthcare organizations with the people they serve; operates as a subsidiary brand under Magnolia Innovation and the Medical Knowledge Group.
• Scout Report

Products and services

• Market Research Primary market research with deep expertise across qualitative and quantitative methodologies, tailored to the healthcare and pharmaceutical fields, with best-in-class facilitation supporting brand challenges and communication objectives across the product lifecycle.
• Healthcare Market Strategy Strategic planning services covering the full brand lifecycle, providing actionable strategies and innovative approaches to navigate market challenges for healthcare and pharmaceutical brands.
• Market Access Quantitative and qualitative health policy analysis combined with pricing, payer marketing and contracting, coding, coverage, reimbursement, packaging and distribution, patient assistance strategy, and real-world evidence to optimize product access; led by Amanda Forys.
• HCP & Patient Analytics Healthcare analytics team applying advanced quantitative techniques to link data with research insights for actionable market intelligence across healthcare professional and patient populations.
• Training Customized training solutions covering clinical education, current market trends, business of oncology, and sales acceleration, tailored to specific organizational needs.
• Market Research Panels
• Scout Report Proprietary insight-connection solution that links primary research, competitive intelligence, claims data, and other secondary resources into a structured scorecard, enabling pharma companies to efficiently triangulate insights for strategic decision-making.

Quantifiable outcome

• Supported Biohaven's migraine launch to become the leading brand in a crowded market against AbbVie as a single market research vendor.
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature2 records

Partnerships

Four partnerships are on record, tiered flagship, core and minor.

• Medical Knowledge Group (MKG)flagshipStrategic or Co-development Partner · 1 January 2024Magnolia Innovation operates as 'a medical knowledge group company.' MKG is the parent organization providing corporate infrastructure, in-house medical affairs and data scientist teams, and shared brand network. Magnolia leverages MKG's broader subsidiary footprint including Flince.
• Flince Research + DesigncoreStrategic or Co-development Partner · 1 January 2024Flince Research has joined the Magnolia Innovation and Medical Knowledge Group family through acquisition. Flince brings innovative qualitative and ethnographic research methodologies that transform how healthcare organizations understand and reach their customers. Nancy McDonald is shown as a Flince contact.
• BMT InfoNet (Blood & Marrow Transplant Information Network)minorStrategic or Co-development PartnerBMT InfoNet partnered with Magnolia Innovation to better understand their community's needs. Magnolia volunteered its market research expertise to identify user-experience issues on BMT InfoNet's website for transplant and CAR T-cell therapy recipients.
• XperiomeminorStrategic or Co-development PartnerXperiome (a global healthtech company specializing in rare disease) and Magnolia Innovation partnered to explore how COVID-19 impacted the rare disease community, including patient and caregiver behaviors and the emotional toll of the pandemic.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Kantar Health: Kantar Health is a global healthcare-focused market research and analytics consultancy offering primary MR, oncology and rare disease expertise, and real-world evidence. Broad incumbent serving the same pharma and biotech buyers as Magnolia.
• IQVIA: IQVIA is the largest global healthcare and life sciences data, analytics, and market research firm. Magnolia's own partner Mark Stevens was previously Senior Principal at IQVIA; IQVIA overlaps Magnolia's qualitative and quantitative MR work but at vastly larger scale and with proprietary data assets.
• Ipsos Healthcare: Ipsos is a global market research conglomerate with a dedicated healthcare practice offering qualitative, quantitative, and ethnographic pharma research. Directly comparable service portfolio to Magnolia but at much larger scale; Magnolia's Jacob Maso previously held roles at Ipsos.

Direct peers

• Trinity Life Sciences: Trinity Life Sciences is a healthcare strategy and market research consultancy serving pharma and biotech with evidence-based insights, commercial strategy, and real-world evidence work. Closely comparable to Magnolia in therapeutic-area expertise, boutique model, and lifecycle services across pre-launch and post-launch.
• ZS Associates: ZS Associates is a global consulting firm with deep pharma and biotech commercial and analytics practices covering sales, marketing, and market research. Comparable to Magnolia in serving pharma commercial teams with analytics-driven insights, though at much larger scale.
• Prescient Healthcare Group: Prescient Healthcare Group is a specialty pharma and biotech strategy and insights firm covering oncology, rare disease, and pipeline strategy. Directly comparable as a boutique competitor competing for similar pre-launch and lifecycle MR mandates in oncology and rare disease.
• Evidera: Evidera (part of Thermo Fisher's PPD clinical research services) provides health economics, outcomes research, market access, and real-world evidence consulting to pharma. Closely comparable to Magnolia's Market Access pillar and broader evidence-generation focus.
• Cello Health (now part of LR Group): Cello Health was a specialist healthcare strategy and market research consultancy offering qualitative and quantitative research, brand strategy, and market access services to global pharma. Directly comparable boutique health-focused MR competitor.

Emerging players

• Schlesinger Group: Schlesinger Group is a global data collection and qualitative research provider with healthcare panel capabilities. Partial overlap with Magnolia's qualitative research and custom panel offerings, focused on data collection and fieldwork infrastructure.

Others

• Medical Knowledge Group (MKG) parent companies/peer agencies: MKG is Magnolia's own parent organization; as a holding structure with 500+ people serving 200+ clients across 315+ brands, MKG and its peer subsidiary agencies (medical communications, consulting) share buyer relationships and overlapping service portfolios with Magnolia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/magnolia-innovation

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magnolia Innovation